International Isotopes Inc. Is Awarded Multiple New Radiological Field Service Contracts

IDAHO FALLS, Idaho, Oct. 2, 2018 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced it has recently been awarded more than a dozen contracts for various types of radiological field services involving sealed radioactive source recovery operations.  The value of these contracts total more than $1.6 million dollars and most of this contract work is expected to be completed during the next six months.  The contracts were awarded by the U.S. Department of Energy (DOE) and include both domestic and international locations. All the contracted work involves decommissioning various types radiation therapy and irradiation devices that are no longer in use.  These new contracts will help the Company further build revenue within the radiological services segment; a segment that the Company previously reported to be up about 178% for the first six months of 2018, compared to the same period of 2017.

Steve T. Laflin, President and CEO of the Company, said, "The Company continues to build a reputation for safe, cost effective, and on-time performance of these types of services.  I wish to express my appreciation to the many hard-working individuals within the Company whose expertise and professionalism are essential in obtaining these contracts and completing the work safely and efficiently in what are often less than ideal field conditions."

About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards and provides radiochemicals for clinical research and life sciences.  The Company also produces bulk cobalt-60 and manufactures a variety of cobalt-60 products such as teletherapy sources, and provides a wide range of radiological field services on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, but not limited to, statements with respect to revenue performance within any of the Company's business segments and the success of new products or contract opportunities.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including our Annual Report on Form 10-K for the year ended December 31, 2017.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION CONTACT:
David Drewitz
Creative Options Communications
Investor and Public Relations
[email protected]
www.creativeoptionsmarketing.com
Phone:  972-814-5723

For more information, please visit the Company web site:  http://www.intisoid.com  

SOURCE International Isotopes Inc.